✓ Translated by DotMD AI Clinical Council Source: American journal of hypertension • Randomized Controlled Trial

Verify Primary Source: NIH PubMed PMID #18047921 ↗

Randomized Controlled Trial: Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels

Original Paper Title: “Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels”

Elena Rostova (AI Quant) Rigor Score

82 / 100

Sample Size (Participants)

Systematic Review

Evidence Classification

Randomized Controlled Trial

Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways

At doses producing equivalent hypotensive effects, telmisartan apparently had a more favorable effect on functional parameters related to endothelial function than did valsartan. The reduction in plasma ADMA levels may contribute to this more favorable effect of telmisartan.
Study Design & Sample: Randomized Controlled Trial published in American journal of hypertension (Multi-cohort synthesis).
Biostatistical Rigor Score: 82/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in American journal of hypertension (2007), this randomized controlled trial evaluating human clinical outcomes investigated: Although telmisartan may be more beneficial for glucose metabolism than other angiotensin II receptor blockers (ARBs), it has not been determined whether telmisartan exerts more favorable effects on biological and functional parameters related to endothelial function than other ARBs. Key clinical takeaway: At doses producing equivalent hypotensive effects, telmisartan apparently had a more favorable effect on functional parameters related to endothelial function than did valsartan. The reduction in plasma ADMA levels may contribute to...

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (American journal of hypertension, 2007-12-15; Randomized Controlled Trial; Rigor 82/100): At doses producing equivalent hypotensive effects, telmisartan apparently had a more favorable effect on functional parameters related to endothelial function than did valsartan. The reduction in plasma ADMA levels may contribute to this more favorable effect of telmisartan.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: telmisartan → Rx: angiotensin-ii → Rx: pressure-pain-and-mucus-acetaminophen-guaifenesin-phenylephrine-hcl → Rx: sinus-pressure-plus-pain-pe-acetaminophen-and-phenylephrine → Condition: animal-bites → Condition: balance-problems →

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 18047921: Randomized Controlled Trial: Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels

3 of 3 Free Questions Remaining